Two Sigma Advisers
VINC

Two Sigma Advisers’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Two Sigma Advisers’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,360
Closed -$38K – 2736
2022
Q3 		$38K Sell
1,360
-115
-8% -$3.31K ﹤0.01% 2393
2022
Q2 		$39K Buy
1,475
+120
+9% +$5.34K ﹤0.01% 2504
2022
Q1 		$108K Buy
+1,355
New +$167K ﹤0.01% 2496

Other funds holding VINC

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SRC
Sage Rhino Capital Menlo Park, California $535M AUM 24.07% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Two Sigma Advisers's VINC Position: Q4 2022 in Review

Two Sigma Advisers sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q4 2022, closing a stake of 1,360 shares — an estimated $38K sold.

Two Sigma Advisers first reported a position in VINC in Q1 2022 and held it in 3 quarters. The position peaked at $108K in Q1 2022. 35 funds tracked by Wall St. Rank hold VINC as of Q4 2022.

  • Two Sigma Advisers reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 1,360 Vincerx Pharma, Inc. Common Stock shares in Q4 2022, an estimated $38K.
  • Two Sigma Advisers first reported a position in Vincerx Pharma, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Two Sigma Advisers's Vincerx Pharma, Inc. Common Stock position peaked at $108K in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.